Protect Pharmaceutical Corp. (PRTT)
0.25
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Protect Pharmaceutical Shareholders Equity (Quarterly) : -0.0245M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0245M |
| March 31, 2026 | -0.0045M |
| June 30, 2025 | 345.88M |
| March 31, 2025 | 339.25M |
| December 31, 2024 | 332.69M |
| September 30, 2024 | 323.63M |
| June 30, 2024 | 296.54M |
| March 31, 2024 | 283.06M |
| December 31, 2023 | 276.36M |
| September 30, 2023 | 261.73M |
| June 30, 2023 | 238.54M |
| March 31, 2023 | 237.89M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 0.0052M |
| December 31, 2021 | 0.50M |
| September 30, 2021 | |
| June 30, 2021 | 6.315M |
| March 31, 2021 | 6.126M |
| December 31, 2020 | 5.890M |
| September 30, 2020 | 5.878M |
| June 30, 2020 | 5.301M |
| March 31, 2020 | 0.0757M |
| December 31, 2019 |
| Date | Value |
|---|---|
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -0.1516M |
| March 31, 2018 | -0.1472M |
| December 31, 2017 | -0.1434M |
| September 30, 2017 | -0.1395M |
| June 30, 2017 | -0.1366M |
| March 31, 2017 | -0.0362M |
| December 31, 2016 | -0.0208M |
| September 30, 2016 | -0.0331M |
| June 30, 2016 | -0.1116M |
| March 31, 2016 | -0.1026M |
| December 31, 2015 | -0.1004M |
| September 30, 2015 | -0.0954M |
| June 30, 2015 | -0.131M |
| March 31, 2015 | -0.1251M |
| December 31, 2014 | -0.121M |
| September 30, 2014 | -0.6002M |
| June 30, 2014 | -0.6043M |
| March 31, 2014 | -0.5957M |
| December 31, 2013 | -0.5951M |
| September 30, 2013 | -0.5926M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| IGC Pharma, Inc. | 6.132M |
| Cryoport, Inc. | 490.70M |
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| GB Sciences, Inc. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.0245M |
| Debt to Equity Ratio | -0.1837 |
| Net Debt Paydown Yield | 17.90% |